ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,994.57
-0.76%
US Tech 100
20,870.80
-0.10%
다우존스 지수
44,421.91
-0.28%
Bitcoin
100,751.82
-0.66%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Centessa Pharmaceuticals PLC (CNTA) 시세

Centessa Pharmaceuticals PLC

Centessa Pharmaceuticals PLC (CNTA)

NASDAQ
16.90
-0.02
(-0.12%)
마감 04 2월 6:00AM
15분 지연
16.90
0.04
(0.24%)
시간외 거래: 7:30AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
16.90
매수가
10.50
매도가
17.55
거래량
504,129
15.56 일간 변동폭 17.16
0.00 52주 범위 0.00
market_cap
2.228B
전일 종가
16.92
개장가
16.49
최근 거래 시간
1273
@
16.9
(priorref)
마지막 거래 시간
재정 규모
US$ 8,509,128
VWAP
16.8789
평균 볼륨(3m)
-
발행 주식
131,845,476
배당수익률
-
주가수익률
0.00
주당순이익(EPS)
-
매출
6.85M
순이익
-151.09M

Centessa Pharmaceuticals PLC 정보

Centessa Pharmaceuticals PLC is a pharmaceutical company. Its portfolio consists of preclinical to phase 3 uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. Some of its products include Vasopressin V2 ... Centessa Pharmaceuticals PLC is a pharmaceutical company. Its portfolio consists of preclinical to phase 3 uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. Some of its products include Vasopressin V2 Receptor Inhibitor (Lixivaptan), BMP9 Engineered Variant (MGX292), OX2R Agonist (Oral) among others. 더 보기

섹터
Coml Physical, Biologcl Resh
산업
Coml Physical, Biologcl Resh
웹사이트
www.centessa.com
본부
Cheshire, Gbr
설립됨
-
Centessa Pharmaceuticals PLC is listed in the Coml Physical, Biologcl Resh sector of the 나스닥 with ticker CNTA. The last closing price for Centessa Pharmaceuticals was US$16.92. Over the last year, Centessa Pharmaceuticals shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Centessa Pharmaceuticals currently has 131,845,476 shares in issue. The market capitalisation of Centessa Pharmaceuticals is US$2.23 billion.

CNTA 최신 뉴스

추가 뉴스

Form 144 - Report of proposed sale of securities

7 시간 전
Edgar (US Regulatory)

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

BOSTON and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational...

28 1월 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

23 1월 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 1월 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

16 1월 2025
Edgar (US Regulatory)

Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer

BOSTON and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical stage pharmaceutical company with a mission to discover, develop and ultimately...

08 1월 2025
GlobeNewswire Inc.

Form 8-K - Current report

08 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

01 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

01 1월 2025
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

CNTA - Frequently Asked Questions (FAQ)

What is the current Centessa Pharmaceuticals share price?
The current share price of Centessa Pharmaceuticals is US$ 16.90
How many Centessa Pharmaceuticals shares are in issue?
Centessa Pharmaceuticals has 131,845,476 shares in issue
What is the market cap of Centessa Pharmaceuticals?
The market capitalisation of Centessa Pharmaceuticals is USD 2.23B
What is the 1 year trading range for Centessa Pharmaceuticals share price?
Centessa Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the reporting currency for Centessa Pharmaceuticals?
Centessa Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Centessa Pharmaceuticals?
The latest annual turnover of Centessa Pharmaceuticals is USD 6.85M
What is the latest annual profit for Centessa Pharmaceuticals?
The latest annual profit of Centessa Pharmaceuticals is USD -151.09M
What is the registered address of Centessa Pharmaceuticals?
The registered address for Centessa Pharmaceuticals is 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, WA14 2DT
What is the Centessa Pharmaceuticals website address?
The website address for Centessa Pharmaceuticals is www.centessa.com
Which industry sector does Centessa Pharmaceuticals operate in?
Centessa Pharmaceuticals operates in the COML PHYSICAL, BIOLOGCL RESH sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
IVVDInvivyd Inc
US$ 1.055
(194.94%)
448.53M
HCWBHCW Biologics Inc
US$ 0.6265
(125.20%)
344.42M
UOKAMDJM Ltd
US$ 0.2293
(76.38%)
354.09M
GHRSGH Research PLC
US$ 17.9991
(69.80%)
10.31M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 234.64
(61.82%)
392
CYNCYNGN Inc
US$ 0.1169
(-56.70%)
75.52M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.1943
(-54.61%)
327.95M
VIRXViracta Therapeutics Inc
US$ 0.0741
(-51.09%)
9.37M
BOWNUBowen Acquisition Corporation
US$ 3.39
(-49.55%)
17.28k
PITAHeramba Electric PLC
US$ 0.503
(-44.11%)
1.37M
IVVDInvivyd Inc
US$ 1.055
(194.94%)
448.53M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0462
(27.98%)
434.24M
NVDANVIDIA Corporation
US$ 116.66
(-2.84%)
371.47M
UOKAMDJM Ltd
US$ 0.2293
(76.38%)
354.09M
HCWBHCW Biologics Inc
US$ 0.6265
(125.20%)
344.42M

CNTA Discussion

게시물 보기
Monksdream Monksdream 10 월 전
CNTA over $10
👍️0
Monksdream Monksdream 12 월 전
CNTA new 52 week high
👍️0

최근 히스토리

NASDAQ
CNTA
Centessa Pharmaceuticals
BOV
PYPL34M
PayPal
DOWI
DWDXTL
DJ Global Developed Ex U...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지